Pamicell, Stock Price 15,850 Won.. Down 11.7% from Previous Day
As of 2:30 PM on the 16th, Pamicell is trading at 15,850 KRW, down 11.7% from the previous day. This represents a 21.92% decrease compared to September 15. Pamicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Today, foreigners have a net purchase of 48,259 shares of Pamicell, while institutions have a net sale of 7,000 shares, according to provisional data. Over the past five days, individual investors have net sold 95,884 shares, while foreigners and institutions have net bought 72,374 shares and 26,090 shares, respectively.


※ Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
"Target Price Set at 970,000 Won"... Top Investors Already Watching, Only an 'Uptrend' Remains [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- While Everyone Focused on Samsung and Nix, This Company Soared 50%... Hit Record Highs for 4 Days [Weekend Money]
- "They Say They Can't Find Jobs, but They Just Don't Want to Work"... 2030s React Strongly to Dongmin Jang's Criticism
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.